Results 121 to 130 of about 10,212 (176)

Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence setting. [PDF]

Int Health
Chew R, Woods ML, Paterson DL.
europepmc   +1 more source

Pneumomediastinum Associated with HIV-positive Pneumocystis jirovecii Pneumonia.

Internal medicine (Tokyo, Japan), 2019
Hosoda, Tomohiro, Sakamoto, Mitsuo
openaire   +2 more sources

The effectiveness of high-dose adjunctive corticosteroid therapy in HIV-negative patients with <i>Pneumocystis jirovecii</i> pneumonia. [PDF]

J Thorac Dis
Wang L, Tan Z, Fan Y, Wang Z, Wang Z, Pan H, Zhang G.   +6 more
europepmc   +1 more source

Prognostic Significance of BALF Neutrophil Percentage and Hypoxemia in Non-HIV <i>Pneumocystis jirovecii</i> Pneumonia: A Retrospective Cohort Study. [PDF]

Infect Drug Resist
Li Y, Li X, Zhao F, Zhou Q, Sun Y.
europepmc   +1 more source

Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays. [PDF]

Diagnostics (Basel)
Neumann FAO, Müller M, Mattert G, Liebig S, Herbst V, Zapf D, Kiderlen TR, Linke C, Arp F, Deckert PM, Lüth S, Schwarzlose-Schwarck S, Dammermann W, Reinwald M.   +13 more
europepmc   +1 more source

Pneumomediastinum and Subcutaneous Emphysema as Initial Presentations of <i>Pneumocystis Jirovecii</i> Pneumonia in a Newly Diagnosed HIV-Infected Patient: A Case Report. [PDF]

J Acute Med
Lai YW, Chen CH.
europepmc   +1 more source

Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis. [PDF]

Infect Drug Resist
Li W, Hua M, Guo J, Jia W.
europepmc   +1 more source

Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report. [PDF]

Front Pharmacol
Zhao Z, Pang L, Liu S, Liu J.
europepmc   +1 more source